Hybridoma Cell Line G7 Producing Monoclonal Anti-mouse CD90 (Thy-1) Antibody

A hybridoma cell line producing a monoclonal rat antibody specific to mouse CD90 (Thy-1) (clone G7) as described in J Exp Med. 1984 Mar 1;159(3):716-30 and developed by the laboratory of Dr. Ethan Shevach at the National Institute of Allergy and Infectious Diseases.

Potential Commercial Applications:		Competitive Advantages:
A research material that can be used in the development of assays, validation of products or in quality control.		Speed up product development with NIH developed material that has already been tested and validated.

Inventors:

Ethan Shevach (NIAID)  ➽ more inventions...


Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 1948-254)

Publications:
Gunter KC, et al. PMID 6142077

Licensing Contact:
Yogikala Prabhu,
Email: prabhuyo@niaid.nih.gov
Phone: 301-761-7789

OTT Reference No: B-004-1991-4
Updated: Dec 4, 2017